Screening chelating inhibitors of HIF-prolyl hydroxylase domain 2 (PHD2) and factor inhibiting HIF (FIH)
about
Imposing function down a (cupin)-barrel: secondary structure and metal stereochemistry in the αKG-dependent oxygenases.Substrate preference of the HIF-prolyl hydroxylase-2 (PHD2) and substrate-induced conformational change.Oxygen sensing strategies in mammals and bacteria.Exploring the influence of the protein environment on metal-binding pharmacophores.Reporter ligand NMR screening method for 2-oxoglutarate oxygenase inhibitors.Unity in diversity, a systems approach to regulating plant cell physiology by 2-oxoglutarate-dependent dioxygenasesModulation of TRP Channel Activity by Hydroxylation and Its Therapeutic Potential.Inverse solvent isotope effects demonstrate slow aquo release from hypoxia inducible factor-prolyl hydroxylase (PHD2)Increased Turnover at Limiting O2 Concentrations by the Thr(387) → Ala Variant of HIF-Prolyl Hydroxylase PHD2.The mitochondrial disulfide relay system: roles in oxidative protein folding and beyond.Hypoxia signalling manipulation for bone regeneration.Recent Advances in Developing Inhibitors for Hypoxia-Inducible Factor Prolyl Hydroxylases and Their Therapeutic Implications.Targeting vascular and leukocyte communication in angiogenesis, inflammation and fibrosis.Co-operative intermolecular kinetics of 2-oxoglutarate dependent dioxygenases may be essential for system-level regulation of plant cell physiology.Investigations on the role of a solvent tunnel in the α-ketoglutarate dependent oxygenase factor inhibiting HIF (FIH).
P2860
Q30155130-581A36CA-926D-44CF-AD30-B4FAA005F58DQ30432207-61A4EF65-34B7-47F2-9677-F3EED14AB8F9Q33897916-FC0C4F5E-7A4D-4318-9113-5DFB5BA49B22Q34104343-6F9DECD2-0A49-498A-A75B-ED77226AFBFFQ34317183-3A4639B0-6804-4146-9D92-0F10B6484B96Q35166815-AB87D4DA-914A-4965-A482-A60DBBDA3344Q36323671-238EF687-DAB8-4C7F-9550-52BFEBE2AC76Q36475425-D25A3E91-60A7-45EF-A54A-43EA41AB9970Q37082434-947E3815-54F8-4CE3-AC99-7F7EF552FD13Q38172143-DCF8A084-429D-47A2-844A-1C3A7627FDE4Q38434373-E93446B9-FE69-486A-B062-CBC13750DA85Q38648760-EB9ABD6E-84F5-4197-836C-BDC69AC6E233Q38650120-B02AE0BA-4ADB-4D88-B9F8-E394C01B5C46Q40667135-1F9763E6-32E2-479F-BCE8-A48111B96A54Q47594814-6045EE37-5091-4092-AFFA-78F13246433F
P2860
Screening chelating inhibitors of HIF-prolyl hydroxylase domain 2 (PHD2) and factor inhibiting HIF (FIH)
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Screening chelating inhibitors ...... nd factor inhibiting HIF (FIH)
@ast
Screening chelating inhibitors ...... nd factor inhibiting HIF (FIH)
@en
Screening chelating inhibitors ...... nd factor inhibiting HIF (FIH)
@nl
type
label
Screening chelating inhibitors ...... nd factor inhibiting HIF (FIH)
@ast
Screening chelating inhibitors ...... nd factor inhibiting HIF (FIH)
@en
Screening chelating inhibitors ...... nd factor inhibiting HIF (FIH)
@nl
prefLabel
Screening chelating inhibitors ...... nd factor inhibiting HIF (FIH)
@ast
Screening chelating inhibitors ...... nd factor inhibiting HIF (FIH)
@en
Screening chelating inhibitors ...... nd factor inhibiting HIF (FIH)
@nl
P2093
P2860
P1476
Screening chelating inhibitors ...... nd factor inhibiting HIF (FIH)
@en
P2093
Breanne E Holmes
Cornelius Y Taabazuing
Cristina B Martin
Michael J Knapp
Shannon C Flagg
P2860
P356
10.1016/J.JINORGBIO.2012.03.002
P407
P577
2012-08-01T00:00:00Z